Skip to main content
. Author manuscript; available in PMC: 2010 Apr 6.
Published in final edited form as: Eur J Pharmacol. 2000 Aug 18;402(1-2):69–76. doi: 10.1016/s0014-2999(00)00503-3

Fig. 2.

Fig. 2

Thermal nociceptive threshold in the absence and presence of dynorphin A-(1–17). Open circles represent tail-withdrawal latencies following s.c. administration of dynorphin A-(1–17) 10 μg in the tail. See Materials and methods and Fig. 1 for other details.